Top

Clinical Research in Cardiology

Published in:

01-07-2017 | Letter to the Editors

Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent

Authors: Vera S. Schneider, Carsten Skurk, Matthias Riedel, Youssef S. Abdelwahed, Ulf Landmesser, David M. Leistner

Published in: Clinical Research in Cardiology | Issue 7/2017

Excerpt

Sirs: …

Jaguszewski M, Ghadri JR, Zipponi M, Bataiosu DR, Diekmann J, Geyer V, Neumann CA, Huber MA, Hagl C, Erne P, Luscher TF, Templin C (2015) Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios. Clin Res Cardiol 104(2):124–135. doi:10.1007/s00392-014-0757-4 CrossRefPubMed

Schinke K, Langwieser N, Laugwitz KL, Ibrahim T (2015) A potential life-threatening complication after implantation of a bioresorbable scaffold for coronary stenting within a mechanically stressed region. Clin Res Cardiol 104(4):366–367. doi:10.1007/s00392-014-0808-x CrossRefPubMed

Gil RJ, Bil J, Pawlowski T, Yuldashev N, Kolakowski L, Janczak J, Jablonski W, Palinski P (2016) The use of bioresorbable vascular scaffold Absorb BVS(R) in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Kardiol Pol 74(7):627–633. doi:10.5603/KP.a2015.0250 CrossRefPubMed

Trobs M, Achenbach S, Rother J, Klinghammer L, Schlundt C (2016) Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Catheter Cardiovasc Interv. doi:10.1002/ccd.26569 PubMed

Raber L, Brugaletta S, Yamaji K, O’Sullivan CJ, Otsuki S, Koppara T, Taniwaki M, Onuma Y, Freixa X, Eberli FR, Serruys PW, Joner M, Sabate M, Windecker S (2015) Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. J Am Coll Cardiol 66(17):1901–1914. doi:10.1016/j.jacc.2015.08.853 CrossRefPubMed

Braun D, Baquet M, Massberg S, Mehilli J, Hausleiter J (2016) Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold. JACC Cardiovasc Interv 9 (1):e13–14. doi:10.1016/j.jcin.2015.10.019 CrossRefPubMed

Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Sabate M, Windecker S, Onuma Y (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479–2491. doi:10.1016/S0140-6736(16)32050-5 CrossRefPubMed

Title: Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent
Authors: Vera S. Schneider
Carsten Skurk
Matthias Riedel
Youssef S. Abdelwahed
Ulf Landmesser
David M. Leistner
Publication date: 01-07-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 7/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-017-1091-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2017

Hypertension up to date: SPRINT to SPYRAL

Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction

Limits of the possible: diagnostic image quality in coronary angiography with third-generation dual-source CT

High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection

In-stent restenosis after interventional treatment of carotid artery stenoses: a long-term follow-up of a single center cohort

Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page